
Breakthrough in Pancreatic Cancer Treatment: How Revolution Medicines’ RAS Inhibitor Is Reshaping Patient Outcomes
Bree Clare - April 28, 2026LISTEN TO OUR PODCAST
THE LATEST FROM PATIENT WORTHY
FEATURED
UPCOMING EVENTS
SIGN UP FOR OUR NEWSLETTER
Breakthrough in Pancreatic Cancer Treatment: How Revolution Medicines' RAS Inhibitor Is Reshaping Patient Outcomes bit.ly/4vKMCmm Read now at PatientWorthy.com
#PatientWorthy #pancreaticcancer #rasinhibitor
... See MoreSee Less

- likes 0
- Shares: 0
- Comments: 0
Cancer Commons #AcutelymphocyticleukemiaHere’s the latest from our Curious Dr. George! Read “How Would a Mayo Clinic Oncologist Manage His Own Acute Lymphocytic Leukemia?” here: bit.ly/CCCDGLitzow
When facing a frightening new cancer diagnosis, some people ask their doctors, “What would you do if you were me?” Here, our Curious Dr. George asks leukemia expert Mark R. Litzow, MD, how he would handle his own hypothetical cancer case. Dr. Litzow is Professor Emeritus in the Division of Hematology at the Mayo Clinic in Minnesota.
#CuriousDrGeorge #ALL #AcuteLymphocyticLukemia #AcuteLymphoblasticLeukemia #PrecisionOncology
... See MoreSee Less

This week, Patient Worthy is focusing on Parkinson’s Disease, sharing educational content to bring greater awareness and understanding to our community.
We’ll be featuring resources and insights on our social channels and patientworthy.com to help inform, empower, and support those living with Parkinson’s.
Interested in sharing your Parkinson’s story? Click the link below to connect with us.
bit.ly/4dV7gru
#ParkinsonsDisease #ParkinsonsAwareness #LivingWithParkinsons #ShareYourStory #PatientWorthy
... See MoreSee Less



